Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 11/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | NR3C1 | P04150 | 5/20 | 0.80 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.80 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.80 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.80 |
| ▸ | SERPINA6 | P08185 | 3/20 | 0.80 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.80 |
| ▸ | MAPT | P10636 | 3/20 | 0.80 |
| ▸ | PGR | P06401 | 2/20 | 0.80 |
| ▸ | SHBG | P04278 | 2/20 | 0.80 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.80 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.80 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.80 |
| ▸ | AR | P10275 | 1/20 | 0.76 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.76 |
| ▸ | MEN1 | O00255 | 1/20 | 0.71 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.71 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.71 |
| ▸ | BLM | P54132 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19327109 | 1.00 | HIF1A (1.00) | HIF1ALMNANR3C1SMN1; SMN2CYP2C19 | |
| SCHEMBL13754708 | 1.00 | HIF1A (1.00) | HIF1ALMNANR3C1SMN1; SMN2CYP2C19 | |
| SCHEMBL3940262 | 1.00 | HIF1A (1.00) | HIF1ALMNANR3C1SMN1; SMN2CYP2C19 | |
| SCHEMBL139279 | 1.00 | HIF1A (1.00) | HIF1ALMNANR3C1SMN1; SMN2CYP2C19 | |
| SCHEMBL2507571 | 1.00 | HIF1A (1.00) | HIF1ALMNANR3C1SMN1; SMN2CYP2C19 | |
| SCHEMBL14523057 | 1.00 | HIF1A (1.00) | HIF1ALMNANR3C1SMN1; SMN2CYP2C19 | |
| SCHEMBL1626384 | 0.92 | HIF1A (0.84) | HIF1ALMNANR3C1SMN1; SMN2CYP2C19 | |
| SCHEMBL1626382 | 0.92 | HIF1A (0.84) | HIF1ALMNANR3C1SMN1; SMN2CYP2C19 | |
| SCHEMBL2484782 | 0.92 | HIF1A (0.84) | HIF1ALMNANR3C1SMN1; SMN2CYP2C19 | |
| SCHEMBL13147966 | 0.92 | HIF1A (0.84) | HIF1ALMNANR3C1SMN1; SMN2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3063 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260148848-A1 | BIOMARKERS FOR DIAGNOSIS AND TREATMENT OF ENDOCRINE HYPERTENSION, AND METHODS OF IDENTIFICATION THEREOF | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2026-05-28 | — | — | US | claimed |
| US-20250279209-A1 | PROVISION OF A MEDICAL RISK ASSESSMENT FOR NONCLASSICAL 21-HYDROXYLASE DEFICIENCY | UNIV SORBONNE (FR) | 2025-09-04 | — | — | US | claimed |
| US-20250231202-A1 | METHOD FOR PREDICTING THE POSTOPERATIVE RISK OF BRAIN-INJURED PATIENTS AND THE USE OF STEROIDS/PROTEINS FOR PREDICTING THE POSTOPERATIVE RISK OF BRAIN-INJURED PATIENTS | TAIPEI MEDICAL UNIVERSITY (TW) | 2025-07-17 | — | — | US | claimed |
| CN-115963199-B | Quantitative detection method and application of steroid hormone in human/animal body fluid | 上海鹿明生物科技有限公司 | 2025-04-29 | — | — | CN | claimed |
| EP-4511660-A1 | PROVISION OF A MEDICAL RISK ASSESSMENT FOR NONCLASSICAL 21-HYDROXYLASE DEFICIENCY | SORBONNE UNIVERSITE (FR) | 2025-02-26 | — | — | EP | claimed |
| US-20250041208-A1 | NEW INJECTABLE COMBINATION FORMULATION | NANEXA AB (SE) | 2025-02-06 | — | — | US | claimed |
| CN-119125357-A | Kit for simultaneously detecting multiple steroid hormones in dried blood spots based on liquid chromatography-mass spectrometry and application of kit | 浙江博圣生物技术股份有限公司 | 2024-12-13 | — | — | CN | claimed |
| CN-119125354-A | Method and kit for measuring various steroid hormones in body fluid by liquid chromatography-mass spectrometry technology | 浙江博圣生物技术股份有限公司 | 2024-12-13 | — | — | CN | claimed |
| CN-119086795-A | Method for simultaneously detecting 5 corticoids in blood sample by liquid chromatography-mass spectrometry | 大连医科大学 | 2024-12-06 | — | — | CN | claimed |
| CN-118961985-A | Kit and method for simultaneously detecting 18 steroid hormones based on double-derivative technology | 上海万子健医学检验实验室有限公司 | 2024-11-15 | — | — | CN | claimed |
| EP-1448205-A4 | COMBINATIONS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS | COMBINATORX INC (US) | 2007-01-03 | — | — | EP | claimed |
| US-20060234991-A1 | Combinations for the treatment of immunoinflammatory disorders | ZALICUS INC. | 2006-10-19 | — | — | US | claimed |
| EP-1448205-A2 | COMBINATIONS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS | Combinatorx, Incorporated (US) | 2004-08-25 | — | — | EP | claimed |
| US-20040072732-A1 | Use of ramoplanin to treat diseases associated with the use of antibiotics | NANOSHIFT, LLC | 2004-04-15 | — | — | US | claimed |
| WO-2003103699-A1 | USE OF RAMOPLANIN TO TREAT DISEASES ASSOCIATED WITH THE USE OF ANTIBIOTICS | VICURON PHARMACEUTICALS INC. (US) | 2003-12-18 | — | — | WO | claimed |
| WO-2003092617-A2 | COMBINATIONS FOR THE TREATMENT OF INFLAMMATORY SKIN DISORDERS | COMBINATORX, INCORPORATED (US) | 2003-11-13 | — | — | WO | claimed |
| US-20030119786-A1 | Combinations for the treatment of immunoinflammatory disorders | ZALICUS INC. | 2003-06-26 | — | — | US | claimed |
| WO-2003030823-A2 | COMBINATIONS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS | COMBINATORX, INCORPORATED (US) | 2003-04-17 | — | — | WO | claimed |
| WO-1997038015-A1 | ARTIFICIAL ANTIBODIES TO CORTICOSTEROIDS PREPARED BY MOLECULAR IMPRINTING | IGEN, INC. (US) | 1997-10-16 | — | — | WO | claimed |
| EP-0238545-B1 | C20 THROUGH C26 AMINO STEROIDS | UPJOHN CO (US) | 1995-11-15 | — | — | EP | claimed |